Company Profile

BioLineRX (NASDAQ: BLRX)
5:00 PM UTC, 07/03/24
Last: $0.53 Change: -0.00 %Change: -0.39% Volume: 299,438
Detailed Quote
Open: $ 0.54   Volume: 299,438
High: $ 0.56   Yield(%) 0.00
Low: $ 0.51   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 42.37M
EPS ($) -0.76   Shares Out: 79.94M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -23.86
% Price Change (last 13 weeks): -35.86
% Price Change (last 26 weeks): -65.23
% Price Change (last 52 weeks): -67.16
% Price Change (year to date): -66.24
Management Effectiveness
Return on Equity (%): -189.23
Return on Assets (%): -86.40
Return on Invested Capital (%): -77.43
Profitability
Gross Profit Margin (%): 3.62
Net Profit Margin (%): -1262.79
Operating Profit Margin (%): -895.65
Price & Volume
50-day Moving Average: $0.65
200-day Moving Average: $1.20
Avg. Daily Vol. (last 50 days): 329,022
Avg. Daily Vol. (last 200 days): 424,959
52-wk high: $2.53
52-wk low: $0.52
Bid: $0.52
Ask: $0.58
Company Information
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
BioLineRX
Modi'in Technology Park 2 HaMa'ayan Street
Modi'in HM 7177871

Phone: 972.8.642.9100
Fax: 972.8.642.9101
http://www.biolinerx.com
Per Share Data
Earnings (1year) ($): -0.76
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.18
Cash Flow ($): -0.82
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 21.01
Price/Book (x): 8.60
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 1.47
Current Ratio (x): 1.53
LT Debt/Equity (x): 59.88
Total Debt/Equity (x): 87.66



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.